24 |
<div align="center">Inflammatory Bowel Disease (IBD)</div> |
<div align="center">Inflammatory Bowel Disease (IBD)</div> |
25 |
</td> |
</td> |
26 |
<td width="24%"> |
<td width="24%"> |
27 |
<div align="center">Preclinical Development</div> |
<div align="center">Clinical Trials</div> |
28 |
</td> |
</td> |
29 |
<td width="31%"> |
<td width="31%"> |
30 |
<div align="center">US$ 600 m. to US$ 1bn</div> |
<div align="center">US$ 600 m. to US$ 1bn</div> |
39 |
Hematology</div> |
Hematology</div> |
40 |
</td> |
</td> |
41 |
<td width="24%"> |
<td width="24%"> |
42 |
<div align="center">Preclinical Development</div> |
<div align="center">Clinical Trials</div> |
43 |
</td> |
</td> |
44 |
<td width="31%"> |
<td width="31%"> |
45 |
<div align="center">US$ 600-900 m.</div> |
<div align="center">US$ 600-900 m.</div> |
53 |
<div align="center">Anti-fungal</div> |
<div align="center">Anti-fungal</div> |
54 |
</td> |
</td> |
55 |
<td width="24%"> |
<td width="24%"> |
56 |
<div align="center">Preclinical Development</div> |
<div align="center">Clinical Trials</div> |
57 |
</td> |
</td> |
58 |
<td width="31%"> |
<td width="31%"> |
59 |
<div align="center">US$ 600-800 m.</div> |
<div align="center">US$ 600-800 m.</div> |